initiates with hepatic accrual along with propagationn towards hepatic inflammation; namely, Non-Alcoholic Steatohepatitis (NASH), hepatic fibrosis/ cirrhosis, with ultimate NAFLD associated Hepatocellular Carcinoma…
most common forms of chronic liver disease which may progress to non-alcoholic steatohepatitis (NASH). Currently there are no therapeutic strategies for such disease. Only lifestyle modification through diet…
Hepatocellular carcinoma (HCC) can have viral or non-viral causes; Non-alcoholic steatohepatitis (NASH) is a significant driver of HCC. Immunotherapy has been supported for treating HCC; however biomarker-based…
result of its nearby relationship with corpulence, insulin opposition and dyslipidaemia. Nonalcoholic steatohepatitis (NASH) is a specific wellbeing worry because of the expanded horribleness and mortality related with…
alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD) and is usually associated with overweight, obesity and metabolic syndrome. The major treatment offered for NAFLD…
weight reduction that leads to significant improvement in liver histology in patients with NASH. Indeed, weight loss improves steatosis, reduces hepatic inflammation and hepatocellular injury and improves cardiovascular…
liver disease spectrum spanning from non-inflammatory isolated steatosis to Non-Alcoholic Steatohepatitis (NASH), a more aggressive form of the disease, which is characterized by steatosis, inflammatory changes and…
inducing nonalcoholic fatty liver disease (NAFLD) and following conditions such as nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. METHODS: In this study, we browsed through the PubMed database by entering…
proteins among serum samples from patients with varying NAFLD and fibrosis stages (NAFL, NASH F0, NASH F1, NASH F3 and healthy individuals). The identified proteins are potential NAFLD biomarkers. Mass
chronic-liverdisease which may be diagnosed incidentally in asymptomatic patients. Non-alcoholic steatohepatitis (NASH) may cause cirrhosis and hepatocellular carcinoma. To date, no established non-invasive test exists…
health and metabolic diseases e.g., non-alcoholic fatty liver disease, (NAFLD), non-alcoholic steatohepatitis, (NASH) and type 2 diabetes mellitus, (T2DM) demonstrates how when glucagon-like peptide ... concentration is…
disease that encompasses a spectrum of disease from simple steatosis to non-alcoholic steatohepatitis (NASH). NASH has the potential to progress to advanced fibrosis and cirrhosis and is associated with ... morbidity…
simple steatosis, which generally follows a benign non-progressive clinical course, and nonalcoholic steatohepatitis (NASH), which may progress to cirrhosis and hepatocellular carcinoma (HCC). The development of…
histological features were evaluated. Histological patterns were classified based on the NIH-sponsored NASH Clinical Research Network NAFLD Activity Score (NAS). Results: Most patients were females (73%), with mean…
survival. Reduction of blood lipids: Statins and Ezetimibe have good effect when used for NASH with dyslipidemia. Antioxidants: Vitamin-E, alone and with vitamin-C, EPL, sylimarin and metformin revealed ... effects…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.